Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax

Nucleic Acids Research

Volumn 36, Issue 16, 2008, Pages 5139-5151

  Patel, Seema ^a   George, Roger ^b   Autore, Flavia ^c   Fraternali, Franca ^c   Ladbury, John E ^b   Nikolova, Penka V ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS STIMULATING P53 PROTEIN 1; APOPTOSIS STIMULATING P53 PROTEIN 2; GENE PRODUCT; PROTEIN BAX; PROTEIN P53; PROTEIN P63; PROTEIN P73; PUMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; STOICHIOMETRY; STRUCTURAL HOMOLOGY;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BINDING SITES; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; DNA-BINDING PROTEINS; MODELS, MOLECULAR; NUCLEAR PROTEINS; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; STRUCTURAL HOMOLOGY, PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 52649151797     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn490     Document Type: Article

References (38)

1. Slee,E.A., O'Connor,D.J. and Lu,X. (2004) To die or not to die: How does p53 decide? Oncogene, 23, 2809-2818.
2. Caelles,C., Helmberg,A. and Karin,M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370, 220-223.
3. Haupt,Y., Rowan,S., Shaulian,E., Vousden,K.H. and Oren,M. (1995) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Der., 9, 2170-2183.
4. Bell,H.S., Dufes,C., O'Prey,J., Crighton,D., Bergamaschi,D., Lu,X., Schatzlein,A.G., Vousden,K.H. and Ryan,K.M. (2007) A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo. J. Clin. Invest., 117, 1008-1018.
5. Ko,L.J. and Prives,C. (1996) p53: Puzzle and paradigm. Genes Der., 10, 1054-1072.
6. Kravchenko,J.E., Ilyinskaya,G.V., Komarov,P.G., Agapova,L.S., Kochetkov,D.V., Strom,E., Frolova,E.I., Kovriga,I., Gudkov,A.V., Feinstein,E. et al. (2008) Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc. Natl Acad. Sci. USA, 105, 6302-6307.
7. Flores,E.R., Tsai,K.Y., Crowley,D., Sengupta,S., Yang,A., McKeon,F. and Jacks,T. (2002) p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature, 416, 560-564.
8. Flores,E.R., Sengupta,S., Miller,J.B., Newman,J.J., Bronson,R., Crowley,D., Yang,A., McKeon,F. and Jacks,T. (2005) Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 family. Cancer Cell, 7, 363-373.
9. Senoo,M., Manis,J.P., Alt,F.W. and McKeon,F. (2004) p63 and p73 are not required for the development and p53-dependent apoptosis of T cells. Cancer Cell, 6, 85-89.
10. Blandino,G. and Dobbelstein,M. (2004) p73 and p63: Why do we still need them? Cell Cycle, 3, 886-894.
11. Urist,M. and Prives,C. (2002) p53 leans on its siblings. Cancer Cell 1, 311-313.
12. Benchimol,S. (2004) p53 - an examination of sibling support in apoptosis control. Cancer Cell, 6, 3-4.
13. Espinosa,J.M. (2008) Mechanisms of regulatory diversity within the p53 transcriptional network. Oncogene, 27, 4013-4023.
14. Samuels-Lev,Y., O'Connor,D.J., Bergamaschi,D., Trigiante,G., Hsieh,J.K., Zhong,S., Campargue,J., Naumovski,L., Crook,T. and Lu,X. (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell, 8, 781-794.
15. Bergamaschi,D., Samuels,Y., Jin,B., Duraisingham,S., Crook,T. and Lu,X. (2004) ASPP1 and ASPP2: Common activators of p53 family members. Mol. Cell Biol., 24, 1341-1350.
16. Iwabuchi,K., Bartel,P.L., Li,B., Marraccino,R. and Fields,S. (1994) Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl Acad. Sci. USA, 91, 6098-6102.
17. Gorina,S. and Pavletich,N.P. (1996) Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science, 274, 1001-1005.
18. Cho,Y., Gorina,S., Jeffrey,P.D. and Pavletich,N.P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science, 265, 346-355.
19. Tidow,H., Veprintsev,D.B., Freund,S.M. and Fersht,A.R. (2006) Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2). J. Biol. Chem., 281, 32526-32533.
20. Tidow,H., Andreeva,A., Rutherford,T.J. and Fersht,A.R. (2007) Solution structure of ASPP2N-terminal domain (N-ASPP2) reveals a ubiquitin-like fold. J. Mol. Biol., 371, 948-958.
21. Robinson,R.A., Lu,X., Jones,E.Y. and Siebold,C. (2008) Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73. Structure, 16, 259-268.
22. Rotem,S., Katz,C., Benyamini,H., Lebendiker,M., Veprintsev,D.B., Rudiger,S., Danieli,T. and Friedler,A. (2008) The structure and interactions of the proline rich domain of ASPP2. J. Biol. Chem., 283, 18990-18999.
23. Patel,S., Bui,T.T., Drake,A.F., Fraternali,F. and Nikolova,P.V. (2008) The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding. Biochemistry, 47, 3235-3244.
24. Bullock,A.N., Henckel,J., DeDecker,B.S., Johnson,C.M., Nikolova,P.V., Proctor,M.R., Lane,D.P. and Fersht,A.R. (1997) Thermodynamic stability of wild-type and mutant p53 core domain. Proc. Natl. Acad. Sci. USA 94, 14338-14342.
25. Nikolova,P.V., Henckel,J., Lane,D.P. and Fersht,A.R. (1998) Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. Proc. Natl. Acad. Sci. USA, 95, 14675-14680.
26. Nikolova,P.V., Wong,K.B., DeDecker,B., Henckel,J. and Fersht,A.R. (2000) Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations. EMBO J., 19, 370-378.
27. Schmid,F.X. (1997) Optical spectroscopy to characterize protein conformation and conformational changes. In Creighton,T.E. (ed.), Protein Structure: A Practical Approach. 2nd edn. Oxford University Press, Oxford, pp. 261-296.
28. Rost,B. (1999) Twilight zone of protein sequence alignments. Protein Eng., 12, 85-94.
29. Notredame,C., Higgins,D.G. and Heringa,J. (2000) T-Coffee: A novel method for fast and accurate multiple sequence alignment. J. Mol. Biol., 302, 205-217.
30. Marti-Renom,M.A., Stuart,A.C., Fiser,A., Sanchez,R., Melo,F. and Sali,A. (2000) Comparative protein structure modeling gene and genomes. Annu. Rev. Biophys. Biomol. Struct., 29, 291-325.
31. Berendsen,H.J.C., van der Spoel,D. and van Drunen,R. (1995) GROMACS: A message-passing molecular dynamics implementation. Comput. Phys. Commun., 91, 43-56.
32. Daura,X., Mark,A.E. and van Gunsteren,W.F. (1998) Parametrization of aliphatic CHn nited atoms of GROMOS96 force field. J. Comput. Chem. 19, 535-547.
33. Humphrey,W., Dalke,A. and Schulten,K. (1996) VMD: Visual molecular dynamics. J. Mol. Graph., 14, 33-38.
34. Kleinjung,J. and Fraternali,F. (2005) POPSCOMP: An automated interaction analysis of biomolecular complexes. Nucleic Acids Res., 33, W342-W346.
35. Fraternali,F. and Cavallo,L. (2002) Parameter optimized surfaces (POPS): analysis of key interactions and conformational changes in the ribosome. Nucleic Acids Res., 30, 2950-2960.
36. DeLano,W.L. (2002) The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, CA, USA.
37. Baker,N.A., Sept,D., Joseph,S., Holst,M.J. and McCammon,J.A. (2001) Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA, 98, 10037-10041.
38. Schon,O., Friedler,A., Bycroft,M., Freund,S.M. and Fersht,A.R. (2002) Molecular mechanism of the interaction between MDM2 and p53. J. Mol. Biol., 323, 491-501.